LLY Jan 2025 350.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:45PM EDT. Market open.
| Previous close | 400.00 |
| Open | 400.00 |
| Bid | 420.00 |
| Ask | 429.00 |
| Strike | 350.00 |
| Expiry date | 2025-01-17 |
| Day's range | 400.00 - 400.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 212 |
ZacksWill Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
Zacks4 Large Drug Stocks to Hold on to Amid Industry Challenges
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.
ZacksAnalysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.